CRISPR Therapeutics (CRSP) PT Raised to $80 at Canaccord Genuity
Canaccord Genuity analyst Arlinda Lee ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
